CAMPISI, RAFFAELE
 Distribuzione geografica
Continente #
EU - Europa 110
NA - Nord America 102
AF - Africa 69
AS - Asia 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 310
Nazione #
US - Stati Uniti d'America 101
IT - Italia 71
CI - Costa d'Avorio 46
IE - Irlanda 30
SN - Senegal 23
CN - Cina 17
IN - India 5
FI - Finlandia 4
HK - Hong Kong 2
NL - Olanda 2
VN - Vietnam 2
AT - Austria 1
CA - Canada 1
DE - Germania 1
EU - Europa 1
FR - Francia 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 310
Città #
Abidjan 46
Ashburn 33
Dublin 30
Dakar 23
Zafferana Etnea 15
Catania 12
Chandler 11
Milan 9
Pune 5
Bari 4
Boardman 4
Helsinki 3
Mascalucia 3
Seattle 3
Abbiategrasso 2
Bitonto 2
Cagliari 2
Corato 2
Dong Ket 2
Laives 2
New York 2
Tai Wan 2
Washington 2
Amsterdam 1
Andover 1
Bremen 1
Cambridge 1
Des Moines 1
Dordrecht 1
Genoa 1
Hebei 1
Lappeenranta 1
Lawrence 1
Los Angeles 1
Messina 1
Nanjing 1
Naples 1
Paris 1
Richmond 1
Trabia 1
Vienna 1
Totale 237
Nome #
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients 46
Female Sex Affects Respiratory Function and Exercise Ability in Patients Recovered from COVID-19 Pneumonia 39
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 21
Sleep quality and mental health during the COVID-19 pandemic in patients with severe obstructive sleep apnea 18
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 17
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 17
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 17
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 16
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 15
Tezepelumab for asthma 14
Impact of asthma on bronchiectasis severity and risk of exacerbations 14
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 13
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 11
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 11
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 11
Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19 10
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 10
Comparability of asthma control test scores between self and physician-administered test 10
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 9
Switching Biological Therapies in Severe Asthma 6
Insuline resistance and insuline sensibility in patients with obstructive sleep apnea 5
Personalized Medicine in Asthma: Current Approach and Future Perspectives 4
Diagnostic delay in bronchiectasis: an Italian perspective 3
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 2
Totale 339
Categoria #
all - tutte 1.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 2 0 0 0 0 0 0 0 0 0 0 0
2020/20214 0 0 0 0 1 1 0 0 0 0 0 2
2021/20225 0 1 0 0 1 0 1 0 0 0 0 2
2022/2023148 1 0 1 4 4 2 53 40 22 10 2 9
2023/2024178 7 32 23 16 9 53 4 27 2 5 0 0
Totale 339